Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$13.5MFederal grants as PI16 awards
0Patents grantedNone matched
43Papers5,525 citations
Federal awards and patents by year
AwardsPatents
16 awards · $13.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 14, 2025 | NIH | SBIR Phase II Rapid and robust assay for measurement of in vivo activity of chromatin-interacting proteins | $1.0M | Epicypher, Inc. |
| Jun 18, 2024 | NIH | SBIR Phase II Rapid and robust assay for measurement of in vivo activity of chromatin-interacting proteins | $1.0M | Epicypher, Inc. |
| May 20, 2024 | NIH | SBIR Phase II Novel recombinant sensors to study histone ubiquitin signaling | $1.3M | Epicypher, Inc. |
| Dec 1, 2022 | NIH | SBIR Phase II Engineered super-affinity reagents for detection of histone post-translational modifications | $1.0M | Epicypher, Inc. |
| Jan 20, 2022 | NIH | SBIR Phase II Engineered super-affinity reagents for detection of histone post-translational modifications | $1.0M | Epicypher, Inc. |
| Jan 26, 2021 | NIH | SBIR Phase II Multiplex nucleosome-based profiling for the development of next-generation chromatin labeling reagents | $920K | Epicypher, Inc. |
| Jul 16, 2020 | NIH | SBIR Phase II Novel enzyme inhibitor screening platform using modified designer nucleosomes | $968K | Epicypher, Inc. |
| Feb 18, 2019 | NIH | SBIR Phase II Accelerated discovery of methylation targeted therapeutic development | $961K | Epicypher, Inc. |
| Jan 30, 2019 | NIH | SBIR Phase II High-throughput methyltransferase assays using recombinant nucleosome substrates | $844K | Epicypher, Inc. |
| Aug 31, 2018 | NIH | SBIR Phase II Barcoded nucleosomes for analyzing combinatorial epigenetic regulators | $806K | Epicypher, Inc. |
| Aug 1, 2018 | NIH | SBIR Phase II Developing Novel Arginine Biased Arrays for Epigenetic Research | $707K | Epicypher, Inc. |
| Jan 29, 2018 | NIH | SBIR Phase II High-throughput methyltransferase assays using recombinant nucleosome substrates | $904K | Epicypher, Inc. |
| Aug 29, 2017 | NIH | SBIR Phase II Barcoded nucleosomes for analyzing combinatorial epigenetic regulators | $773K | Epicypher, Inc. |
| Aug 1, 2017 | NIH | SBIR Phase II Developing Novel Arginine Biased Arrays for Epigenetic Research | $793K | Epicypher, Inc. |
| Feb 23, 2017 | NIH | SBIR Phase I Novel enzyme inhibitor screening platform using modified designer nucleosomes | $225K | Epicypher, Inc. |
| Jun 29, 2016 | NIH | SBIR Phase I Rapid manufacturing of recombinant nucleosomes for high-throughput assays | $224K | Epicypher, Inc. |
1 patents as inventor
- US Epicypher, Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#29
Awards as PI#37
Patents#273
Companies
- Epicypher, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.